Compare ERAS & VKQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
Invesco Municipal Trust is a diversified, closed-end management investment company. The company's investment objective is to provide a high level of current income exempt from federal income tax, consistent with the preservation of capital.